鄧 承德

Medicine & Life Sciences

1. Artificial Intelligence 100%
2. Coronavirus 94%
3. Acute Lung Injury 85%
4. Machine Learning 85%
5. X-Rays 58%
6. Thorax 52%
7. B-Lymphocytes 33%
8. Clavicle 31%
9. Psychology Transfer 29%
10. Triage 27%
11. Severe Acute Respiratory Syndrome 27%
12. Efficiency 27%
13. T-Lymphocytes 26%
14. Mechanical Ventilators 26%
15. Feasibility Studies 26%
16. Adult Respiratory Distress Syndrome 23%
17. Ventilation 22%
18. Plasma Cells 21%
19. Regulatory T-Lymphocytes 21%
20. Cell- and Tissue-Based Therapy 20%
21. Critical Illness 20%
22. Monocytes 17%
23. lactate dehydrogenase C4 17%
24. Stem Cells 15%
25. Cytokines 13%
26. Lymphopenia 13%
27. Therapeutics 12%
28. Interleukin-13 12%
29. Interleukin-5 11%
30. Pandemics 11%
31. Lung Injury 11%
32. Ferritins 11%
33. Adaptive Immunity 10%
34. Mortality 10%
35. Interleukin-1 10%
36. Intravenous Infusions 10%
37. Placenta 10%
38. Innate Immunity 9%
39. Mesenchymal Stem Cells 9%
40. Dendritic Cells 9%
41. Interleukin-2 9%
42. C-Reactive Protein 9%
43. Immunosuppressive Agents 8%
44. Interleukin-6 8%
45. Flow Cytometry 8%
46. Biomarkers 7%
47. Control Groups 5%
48. Health 5%
49. Infections 5%